Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study. (Q53446914)
Jump to navigation
Jump to search
scientific article published in January 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study. |
scientific article published in January 2013 |
Statements
Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study. (English)
1 reference
Jaren W Landen
1 reference
Qinying Zhao
1 reference
Sharon Cohen
1 reference
Michael Borrie
1 reference
Michael Woodward
1 reference
Clare B Billing
1 reference
Kelly Bales
1 reference
Christine Alvey
1 reference
Fred McCush
1 reference
Jerry Yang
1 reference
James W Kupiec
1 reference
Martin M Bednar
1 reference
1 January 2013
1 reference
36
1 reference
1
1 reference
14-23
1 reference
Identifiers
1 reference